Top

Published in:

01-12-2017 | Original Article

A Combination of Three Repurposed Drugs Administered at Reperfusion as a Promising Therapy for Postischemic Brain Injury

Authors: I-Chen Yu, Ping-Chang Kuo, Jui-Hung Yen, Hallel C. Paraiso, Eric T. Curfman, Benecia C. Hong-Goka, Robert D. Sweazey, Fen-Lei Chang

Published in: Translational Stroke Research | Issue 6/2017

Abstract

Cerebral ischemia leads to multifaceted injury to the brain. A polytherapeutic drug that can be administered immediately after reperfusion may increase protection to the brain by simultaneously targeting multiple deleterious cascades. This study evaluated efficacy of the combination of three clinically approved drugs: lamotrigine, minocycline, and lovastatin, using two mouse models: global and focal cerebral ischemia induced by transient occlusion of the common carotid arteries or the middle cerebral artery, respectively. In vitro, the combination drug, but not single drug, protected neurons against oxygen-glucose deprivation (OGD)-induced cell death. The combination drug simultaneously targeted cell apoptosis and DNA damage induced by ischemia. Besides acting on neurons, the combination drug suppressed inflammatory processes in microglia and brain endothelial cells induced by ischemia. In a transient global ischemia model, the combination drug, but not single drug, suppressed microglial activation and inflammatory cytokine production, and reduced neuronal damage. In a transient focal ischemia model, the combination drug, but not single drug, attenuated brain infarction, suppressed infiltration of peripheral neutrophils, and reduced neurological deficits following ischemic stroke. In summary, the combination drug confers a broad-spectrum protection against ischemia/reperfusion (I/R) injury and could be a promising approach for early neuroprotection after out-of-hospital cardiac arrest or ischemic stroke.

Available only for authorised users

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38–e360. doi:10.1161/CIR.0000000000000350.CrossRefPubMed

Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, et al. Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med. 2013;369(23):2197–206. doi:10.1056/NEJMoa1310519.CrossRefPubMed

Haugk M, Testori C, Sterz F, Uranitsch M, Holzer M, Behringer W, et al. Relationship between time to target temperature and outcome in patients treated with therapeutic hypothermia after cardiac arrest. Crit Care. 2011;15(2):R101. doi:10.1186/cc10116.CrossRefPubMedPubMedCentral

MacLaren R, Gallagher J, Shin J, Varnado S, Nguyen L. Assessment of adverse events and predictors of neurological recovery after therapeutic hypothermia. Ann Pharmacother. 2014;48(1):17–25. doi:10.1177/1060028013511228.CrossRefPubMed

Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17(7):796–808. doi:10.1038/nm.2399.CrossRefPubMedPubMedCentral

Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67(2):181–98. doi:10.1016/j.neuron.2010.07.002.CrossRefPubMedPubMedCentral

Papazisis G, Kallaras K, Kaiki-Astara A, Pourzitaki C, Tzachanis D, Dagklis T, et al. Neuroprotection by lamotrigine in a rat model of neonatal hypoxic-ischaemic encephalopathy. Int J Neuropsychopharmacol. 2008;11(3):321–9. doi:10.1017/S1461145707008012.CrossRefPubMed

Smith SE, Meldrum BS. Cerebroprotective effect of lamotrigine after focal ischemia in rats. Stroke. 1995;26(1):117–21. discussion 21-2CrossRefPubMed

Fagan SC, Cronic LE, Hess DC. Minocycline development for acute ischemic stroke. Transl Stroke Res. 2011;2(2):202–8. doi:10.1007/s12975-011-0072-6.CrossRefPubMedPubMedCentral

10.

Ni Chroinin D, Asplund K, Asberg S, Callaly E, Cuadrado-Godia E, Diez-Tejedor E, et al. Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. Stroke. 2013;44(2):448–56. doi:10.1161/STROKEAHA.112.668277.CrossRefPubMed

11.

Antoniades C, Bakogiannis C, Leeson P, Guzik TJ, Zhang MH, Tousoulis D, et al. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circulation. 2011;124(3):335–45. doi:10.1161/CIRCULATIONAHA.110.985150.CrossRefPubMedPubMedCentral

12.

Lokk J, Delbari A. Management of depression in elderly stroke patients. Neuropsychiatr Dis Treat. 2010;6:539–49. doi:10.2147/NDT.S7637.CrossRefPubMedPubMedCentral

13.

Silverman IE, Restrepo L, Mathews GC. Poststroke seizures. Arch Neurol. 2002;59(2):195–201.CrossRefPubMed

14.

Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG, van de Beek D. Post-stroke infection: a systematic review and meta-analysis. BMC Neurol. 2011;11:110. doi:10.1186/1471-2377-11-110.CrossRefPubMedPubMedCentral

15.

Han H, Qian Q, Yu Y, Zhao D, Sun G. Lamotrigine attenuates cerebral ischemia-induced cognitive impairment and decreases beta-amyloid and phosphorylated tau in the hippocampus in rats. Neuroreport. 2015;26(12):723–7. doi:10.1097/WNR.0000000000000424.CrossRefPubMed

16.

Matsukawa N, Yasuhara T, Hara K, Xu L, Maki M, Yu G, et al. Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. BMC Neurosci. 2009;10:126. doi:10.1186/1471-2202-10-126.CrossRefPubMedPubMedCentral

17.

Potey C, Ouk T, Petrault O, Petrault M, Berezowski V, Salleron J, et al. Early treatment with atorvastatin exerts parenchymal and vascular protective effects in experimental cerebral ischaemia. Br J Pharmacol. 2015;172(21):5188–98. doi:10.1111/bph.13285.CrossRefPubMedPubMedCentral

18.

Murakami K, Kondo T, Kawase M, Chan PH. The development of a new mouse model of global ischemia: focus on the relationships between ischemia duration, anesthesia, cerebral vasculature, and neuronal injury following global ischemia in mice. Brain Res. 1998;780(2):304–10.CrossRefPubMed

19.

Walker EJ, Rosenberg GA. TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia. Exp Neurol. 2009;216(1):122–31. doi:10.1016/j.expneurol.2008.11.022.CrossRefPubMed

20.

Yoshioka H, Niizuma K, Katsu M, Okami N, Sakata H, Kim GS, et al. NADPH oxidase mediates striatal neuronal injury after transient global cerebral ischemia. J Cereb Blood Flow Metab. 2011;31(3):868–80. doi:10.1038/jcbfm.2010.166.CrossRefPubMed

21.

Zhen G, Dore S. Optimized protocol to reduce variable outcomes for the bilateral common carotid artery occlusion model in mice. J Neurosci Methods. 2007;166(1):73–80. doi:10.1016/j.jneumeth.2007.06.029.CrossRefPubMedPubMedCentral

22.

Wellons JC 3rd, Sheng H, Laskowitz DT, Mackensen GB, Pearlstein RD, Warner DS. A comparison of strain-related susceptibility in two murine recovery models of global cerebral ischemia. Brain Res. 2000;868(1):14–21.CrossRefPubMed

23.

Yang G, Kitagawa K, Matsushita K, Mabuchi T, Yagita Y, Yanagihara T, et al. C57BL/6 strain is most susceptible to cerebral ischemia following bilateral common carotid occlusion among seven mouse strains: selective neuronal death in the murine transient forebrain ischemia. Brain Res. 1997;752(1–2):209–18.CrossRefPubMed

24.

Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84–91.CrossRefPubMed

25.

Kuo PC, Scofield BA, Yu IC, Chang FL, Ganea D, Yen JH. Interferon-beta modulates inflammatory response in cerebral ischemia. J Am Heart Assoc. 2016;5(1) doi:10.1161/JAHA.115.002610.

26.

Kunze R, Urrutia A, Hoffmann A, Liu H, Helluy X, Pham M, et al. Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity. Exp Neurol. 2015;266:99–111. doi:10.1016/j.expneurol.2015.02.022.CrossRefPubMed

27.

Liu DZ, Xie KQ, Ji XQ, Ye Y, Jiang CL, Zhu XZ. Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonists. Br J Pharmacol. 2005;146(4):604–11. doi:10.1038/sj.bjp.0706335.CrossRefPubMedPubMedCentral

28.

Li Y, Maher P, Schubert D. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron. 1997;19(2):453–63.CrossRefPubMed

29.

Suo Z, Wu M, Citron BA, Palazzo RE, Festoff BW. Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling. J Biol Chem. 2003;278(39):37681–9. doi:10.1074/jbc.M301406200.CrossRefPubMed

30.

Liu J, Li L, Suo WZ. HT22 hippocampal neuronal cell line possesses functional cholinergic properties. Life Sci. 2009;84(9–10):267–71. doi:10.1016/j.lfs.2008.12.008.CrossRefPubMed

31.

He M, Liu J, Cheng S, Xing Y, Suo WZ. Differentiation renders susceptibility to excitotoxicity in HT22 neurons. Neural Regen Res. 2013;8(14):1297–306. doi:10.3969/j.issn.1673-5374.2013.14.006.PubMedPubMedCentral

32.

Goldberg MP, Choi DW. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci. 1993;13(8):3510–24.PubMed

33.

Sasaki T, Takemori H, Yagita Y, Terasaki Y, Uebi T, Horike N, et al. SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB. Neuron. 2011;69(1):106–19. doi:10.1016/j.neuron.2010.12.004.CrossRefPubMed

34.

Kang Y, Tiziani S, Park G, Kaul M, Paternostro G. Cellular protection using Flt3 and PI3Kalpha inhibitors demonstrates multiple mechanisms of oxidative glutamate toxicity. Nat Commun. 2014;5:3672. doi:10.1038/ncomms4672.PubMedPubMedCentral

35.

Ponomarev ED, Shriver LP, Dittel BN. CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation. J Immunol. 2006;176(3):1402–10.CrossRefPubMed

36.

Chalkias A, Xanthos T. Post-cardiac arrest brain injury: pathophysiology and treatment. J Neurol Sci. 2012;315(1–2):1–8. doi:10.1016/j.jns.2011.12.007.CrossRefPubMed

37.

Horn M, Schlote W. Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia. Acta Neuropathol. 1992;85(1):79–87.CrossRefPubMed

38.

Nagao K. Therapeutic hypothermia following resuscitation. Curr Opin Crit Care. 2012;18(3):239–45. doi:10.1097/MCC.0b013e3283523f4a.CrossRefPubMed

39.

Petito CK, Feldmann E, Pulsinelli WA, Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology. 1987;37(8):1281–6.CrossRefPubMed

40.

Badhiwala JH, Nassiri F, Alhazzani W, Selim MH, Farrokhyar F, Spears J, et al. Endovascular thrombectomy for acute ischemic stroke: a meta-analysis. JAMA. 2015;314(17):1832–43. doi:10.1001/jama.2015.13767.CrossRefPubMed

41.

Campbell BC, Donnan GA, Lees KR, Hacke W, Khatri P, Hill MD, et al. Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke. Lancet Neurol. 2015;14(8):846–54. doi:10.1016/S1474-4422(15)00140-4.CrossRefPubMed

42.

Sutherland BA, Neuhaus AA, Couch Y, Balami JS, DeLuca GC, Hadley G, et al. The transient intraluminal filament middle cerebral artery occlusion model as a model of endovascular thrombectomy in stroke. J Cereb Blood Flow Metab. 2016;36(2):363–9. doi:10.1177/0271678X15606722.CrossRefPubMed

43.

Amantea D, Micieli G, Tassorelli C, Cuartero MI, Ballesteros I, Certo M, et al. Rational modulation of the innate immune system for neuroprotection in ischemic stroke. Front Neurosci. 2015;9:147. doi:10.3389/fnins.2015.00147.CrossRefPubMedPubMedCentral

44.

Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, et al. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol. 2007;6(12):1045–53. doi:10.1016/S1474-4422(07)70270-3.CrossRefPubMed

45.

Kernt M, Hirneiss C, Neubauer AS, Kampik A. Minocycline is cytoprotective in human corneal endothelial cells and induces anti-apoptotic B-cell CLL/lymphoma 2 (Bcl-2) and X-linked inhibitor of apoptosis (XIAP). Br J Ophthalmol. 2010;94(7):940–6. doi:10.1136/bjo.2009.165092.CrossRefPubMed

46.

Xing C, Levchenko T, Guo S, Stins M, Torchilin VP, Lo EH. Delivering minocycline into brain endothelial cells with liposome-based technology. J Cereb Blood Flow Metab. 2012;32(6):983–8. doi:10.1038/jcbfm.2012.48.CrossRefPubMedPubMedCentral

47.

Lee CY, Fu WM, Chen CC, Su MJ, Liou HH. Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus. Epilepsia. 2008;49(5):888–97. doi:10.1111/j.1528-1167.2007.01526.x.CrossRefPubMed

48.

Flint AC, Kamel H, Navi BB, Rao VA, Faigeles BS, Conell C, et al. Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke. 2012;43(1):147–54. doi:10.1161/STROKEAHA.111.627729.CrossRefPubMed

49.

Selim MH, Molina CA. High-dose statin for every stroke: the good, the bad, and the unknown. Stroke. 2012;43(7):1996–7. doi:10.1161/STROKEAHA.111.648832.CrossRefPubMed

50.

He X, Jenner AM, Ong WY, Farooqui AA, Patel SC. Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury. J Neuropathol Exp Neurol. 2006;65(7):652–63. doi:10.1097/01.jnen.0000225906.82428.69.CrossRefPubMed

51.

Meske V, Albert F, Richter D, Schwarze J, Ohm TG. Blockade of HMG-CoA reductase activity causes changes in microtubule-stabilizing protein tau via suppression of geranylgeranylpyrophosphate formation: implications for Alzheimer’s disease. Eur J Neurosci. 2003;17(1):93–102.CrossRefPubMed

52.

Russo E, di Donato Paola E, Gareri P, Siniscalchi A, Labate A, Gallelli L, et al. Pharmacodynamic potentiation of antiepileptic drugs’ effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacol Res. 2013;70(1):1–12. doi:10.1016/j.phrs.2012.12.002.CrossRefPubMed

53.

Fagan SC, Waller JL, Nichols FT, Edwards DJ, Pettigrew LC, Clark WM, et al. Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke. 2010;41(10):2283–7. doi:10.1161/STROKEAHA.110.582601.CrossRefPubMedPubMedCentral

54.

Gimeno-Bayon J, Lopez-Lopez A, Rodriguez MJ, Mahy N. Glucose pathways adaptation supports acquisition of activated microglia phenotype. J Neurosci Res. 2014;92(6):723–31. doi:10.1002/jnr.23356.CrossRefPubMed

55.

Masuda T, Croom D, Hida H, Kirov SA. Capillary blood flow around microglial somata determines dynamics of microglial processes in ischemic conditions. Glia. 2011;59(11):1744–53. doi:10.1002/glia.21220.CrossRefPubMedPubMedCentral

56.

Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation. 2008;5:46. doi:10.1186/1742-2094-5-46.CrossRefPubMedPubMedCentral

57.

Denes A, Vidyasagar R, Feng J, Narvainen J, McColl BW, Kauppinen RA, et al. Proliferating resident microglia after focal cerebral ischaemia in mice. J Cereb Blood Flow Metab. 2007;27(12):1941–53. doi:10.1038/sj.jcbfm.9600495.CrossRefPubMed

58.

Benakis C, Garcia-Bonilla L, Iadecola C, Anrather J. The role of microglia and myeloid immune cells in acute cerebral ischemia. Front Cell Neurosci. 2014;8:461. doi:10.3389/fncel.2014.00461.PubMed

59.

Garcia-Bonilla L, Moore JM, Racchumi G, Zhou P, Butler JM, Iadecola C, et al. Inducible nitric oxide synthase in neutrophils and endothelium contributes to ischemic brain injury in mice. J Immunol. 2014;193(5):2531–7. doi:10.4049/jimmunol.1400918.CrossRefPubMedPubMedCentral

60.

Stowe AM, Adair-Kirk TL, Gonzales ER, Perez RS, Shah AR, Park TS, et al. Neutrophil elastase and neurovascular injury following focal stroke and reperfusion. Neurobiol Dis. 2009;35(1):82–90. doi:10.1016/j.nbd.2009.04.006.CrossRefPubMedPubMedCentral

61.

Gelderblom M, Weymar A, Bernreuther C, Velden J, Arunachalam P, Steinbach K, et al. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood. 2012;120(18):3793–802. doi:10.1182/blood-2012-02-412726.CrossRefPubMed

62.

Allen C, Thornton P, Denes A, McColl BW, Pierozynski A, Monestier M, et al. Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA. J Immunol. 2012;189(1):381–92. doi:10.4049/jimmunol.1200409.CrossRefPubMedPubMedCentral

63.

Maynard C, Longstreth WT Jr, Nichol G, Hallstrom A, Kudenchuk PJ, Rea T, et al. Effect of prehospital induction of mild hypothermia on 3-month neurological status and 1-year survival among adults with cardiac arrest: long-term follow-up of a randomized, clinical trial. J Am Heart Assoc. 2015;4(3):e001693. doi:10.1161/JAHA.114.001693.CrossRefPubMedPubMedCentral

64.

Zhao D, Abella BS, Beiser DG, Alvarado JP, Wang H, Hamann KJ, et al. Intra-arrest cooling with delayed reperfusion yields higher survival than earlier normothermic resuscitation in a mouse model of cardiac arrest. Resuscitation. 2008;77(2):242–9. doi:10.1016/j.resuscitation.2007.10.015.CrossRefPubMed

65.

Diao M, Huang F, Guan J, Zhang Z, Xiao Y, Shan Y, et al. Prehospital therapeutic hypothermia after cardiac arrest: a systematic review and meta-analysis of randomized controlled trials. Resuscitation. 2013;84(8):1021–8. doi:10.1016/j.resuscitation.2013.02.003.CrossRefPubMed

66.

Scolletta S, Taccone FS, Nordberg P, Donadello K, Vincent JL, Castren M. Intra-arrest hypothermia during cardiac arrest: a systematic review. Crit Care. 2012;16(2):R41. doi:10.1186/cc11235.CrossRefPubMedPubMedCentral

67.

Audebert HJ, Saver JL, Starkman S, Lees KR, Endres M. Prehospital stroke care: new prospects for treatment and clinical research. Neurology. 2013;81(5):501–8. doi:10.1212/WNL.0b013e31829e0fdd.CrossRefPubMedPubMedCentral

68.

Ebinger M, Winter B, Wendt M, Weber JE, Waldschmidt C, Rozanski M, et al. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA. 2014;311(16):1622–31. doi:10.1001/jama.2014.2850.CrossRefPubMed

Title: A Combination of Three Repurposed Drugs Administered at Reperfusion as a Promising Therapy for Postischemic Brain Injury
Authors: I-Chen Yu
Ping-Chang Kuo
Jui-Hung Yen
Hallel C. Paraiso
Eric T. Curfman
Benecia C. Hong-Goka
Robert D. Sweazey
Fen-Lei Chang
Publication date: 01-12-2017
Publisher: Springer US
Published in: Translational Stroke Research / Issue 6/2017
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI: https://doi.org/10.1007/s12975-017-0543-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A Combination of Three Repurposed Drugs Administered at Reperfusion as a Promising Therapy for Postischemic Brain Injury

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2017

MicroRNA Changes in Preconditioning-Induced Neuroprotection

Annexin A2 Plus Low-Dose Tissue Plasminogen Activator Combination Attenuates Cerebrovascular Dysfunction After Focal Embolic Stroke of Rats

Novel Regenerative Therapies Based on Regionally Induced Multipotent Stem Cells in Post-Stroke Brains: Their Origin, Characterization, and Perspective

Early Increased Bradykinin 1 Receptor Contributes to Hemorrhagic Transformation After Ischemic Stroke in Type 1 Diabetic Rats

CCL11 (Eotaxin-1) Levels Predict Long-Term Functional Outcomes in Patients Following Ischemic Stroke

Infections Up to 76 Days After Stroke Increase Disability and Death